Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Sunday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Up 3.3%

Shares of NYSE:AMPE opened at $0.00 on Friday. The company has a market capitalization of $3,518.50, a PE ratio of 0.00 and a beta of 3.90. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $0.45.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.